Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma

Podobne knjige/članki

• Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma
  od: Inwards, D. J., et al.
  Izdano: (2014)
• Temsirolimus and Rituximab in Patients with Relapsed or Refractory Mantle Cell Lymphoma: a multi-center Phase 2 Study
  od: Ansell, Stephen M., et al.
  Izdano: (2011)
• Long-term Results of the Treatment of Patients With Mantle Cell Lymphoma With Cladribine (2-CDA) Alone (95-80-53) or 2-CDA and Rituximab (N0189) in the North Central Cancer Treatment Group
  od: Inwards, David J., et al.
  Izdano: (2008)
• Initial therapy of mantle cell lymphoma
  od: Inwards, David J., et al.
  Izdano: (2011)
• Low-Dose, Single-Agent Temsirolimus for Relapsed Mantle Cell Lymphoma: A Phase 2 Trial in the North Central Cancer Treatment Group
  od: Ansell, Stephen M., et al.
  Izdano: (2008)